Fortrea Convenes New Site Advisory Board
Fortrea’s Site Advisory Board brings research leaders together to focus on evolving site, sponsor and patient relationships DURHAM, N.C., Dec. 13, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it convened last week the inaugural meeting of its Site Advisory Board, a collaboration between clinical […]
Continue Reading